China Innovation, Global Opportunities | Tongee Medical Debuts at the 8th China International Import Expo, Launching the Gastric Bypass Stent as an "Innovation Badge"

From November 5 to 10, 2025, the 8th China International Import Expo (CIIE) was grandly held in Shanghai. As a pioneering leader in China’s metabolic disease interventional treatment field, Tongee Medical not only received the "Medical Innovation Award" from the Import Expo Medical Devices Special Committee, but also showcased on the global stage a "Chinese Model"—a solution that effectively addresses clinical pain points in China while possessing broad international applicability.

Another Honor, the "Medical Innovation Award" Demonstrates R&D Strength

Centered on original research and development technology and oriented toward clinical value, Tongee Medical’s unwavering commitment remains the same. Recently, the Gastric Bypass Stent System was honored with the "Technical Innovation Award" at the “Medical Innovation, Outstanding Products Implemented in China" selection, which is organized by the Import Expo Medical Devices Special Committee and hosted by Wanjiang Innovation. Its breakthrough design of “super minimally invasive and safe reversible”, along with its outstanding clinical benefits of “significant weight reduction and multiple metabolic advantages,” exemplify Chinese innovation with global relevance. As a recommended product, it was showcased at the 2025 International Medical Innovation Forum and the Import Expo Medical Innovation Incubation Boutique Zone.

During the forum, Tongee Medical engaged with government officials, leading international industry experts, and investment institutions to explore future trends in medical innovation. While demonstrating China's original technological breakthroughs, the company also conveyed an open attitude of integrating into the global medical innovation ecosystem and promoting interdisciplinary collaboration. Leveraging its robust technological strength and ecosystem building value, Tongee Medical stood out among six recommended products and once again received the "Medical Innovation Award." This prestigious honor further solidifies its industry position as a benchmark for China’s original technology and strengthens China’s voice and influence on the international medical stage.

First Appearance, CIIE Platform Connects Global Resources

With the dual forces of "technological breakthroughs and ecological synergy," Tongee Medical aims to propel the global metabolic disease treatment system toward “minimally invasive, precise, and personalized” approaches—its core vision demonstrated during the CIIE.

The CIIE Medical Innovation Incubation Zone serves as a one-stop platform for showcasing world-class medical technologies and facilitating resource exchange. It introduced 46 innovative medical projects from 12 countries and regions. As an outstanding representative of China’s original research strength, Tongee Medical’s presence in this zone underscores its leading global technological achievements and highlights the competitiveness of Chinese innovation in international medical technology frontiers.

At the exhibition site, Tongee Medical presented the technological advantages and clinical value of the gastric bypass stent system to global experts, buyers, and partners. This effort challenged traditional perceptions of "Made in China" in international markets and established a high-end brand image of “Chinese Innovation” in the field of metabolic disease intervention. Utilizing the international platform of the CIIE, Tongee Medical further deepened cooperation with top global healthcare institutions, research organizations, and industry investors, accelerating the global translation and implementation of its technological innovations.

Open Cooperation, China’s Innovation Integrates into the Global Landscape

This successful debut at the CIIE marks Tongee Medical’s multi-level and comprehensive empowerment from "national recognition" to "market practice." The accolade and participation not only affirm its past innovation achievements but also serve as a strategic opportunity to transform its identity as a "Chinese innovator" into market, cooperation, and strategic advantages.

Looking ahead, Tongee Medical will continue to embrace open collaboration, integrating China’s original research and innovation into the global healthcare network. From promoting innovative therapies and co-developing treatment standards to optimizing patient services, it aims to comprehensively support the transformation of the global metabolic disease treatment ecosystem and leave a distinct Chinese mark on the international medical landscape.